Germline large genomic alterations on 7q in patients with multiple primary cancers.

scientific article published on 31 January 2017

Germline large genomic alterations on 7q in patients with multiple primary cancers. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/SREP41677
P932PMC publication ID5282589
P698PubMed publication ID28139749

P50authorMaria Isabel AchatzQ42720491
Silvia Regina RogattoQ85467617
P2093author name stringA F Nóbrega
L M Canto
R A R Villacis
T R Basso
P2860cites workGermline copy number variation and cancer riskQ37728292
Molecular mechanisms of genomic imprinting and clinical implications for cancerQ37831991
The consequences of uniparental disomy and copy number neutral loss-of-heterozygosity during human development and cancerQ37886251
Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivorsQ38093037
Multiple primary cancers as a guide to heritabilityQ38221583
-7/7q- syndrome in myeloid-lineage hematopoietic malignancies: attempts to understand this complex disease entityQ38226741
Hereditary breast cancer syndromes and genetic testingQ38266306
Restoration of IGF2 imprinting by polycomb repressive complex 2 docking factor SUZ12 in colon cancer cellsQ38832417
A population-based single nucleotide polymorphism array analysis of genomic aberrations in younger adult acute lymphoblastic leukemia patientsQ41366254
Revisiting Li-Fraumeni Syndrome From TP53 Mutation CarriersQ41715495
A Novel 23.1 Mb Interstitial Deletion Involving 7q22.3q32.1 in a Girl with Short Stature, Motor Delay, and Craniofacial DysmorphismQ41928305
Testin is a tumor suppressor and prognostic marker in breast cancerQ42831001
Absence of a paternally inherited FOXP2 gene in developmental verbal dyspraxiaQ24672211
Clinicopathological relevance of BRAF mutations in human cancerQ27278038
Global cancer statistics, 2012Q27860501
Frequent loss of imprinting of PEG1/MEST in invasive breast cancerQ28146265
Promoter switch: a novel mechanism causing biallelic PEG1/MEST expression in invasive breast cancerQ28218774
Differential expression of mimecan and thioredoxin domain-containing protein 5 in colorectal adenoma and cancer: a proteomic studyQ28250643
Human chromosome fragilityQ28261002
Inactivating CUX1 mutations promote tumorigenesisQ28303563
Cancer treatment and survivorship statistics, 2014Q29617702
Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regionsQ30476046
Association between acquired uniparental disomy and homozygous mutations and HER2/ER/PR status in breast cancerQ33770092
Expanding the genetic basis of copy number variation in familial breast cancer.Q33780936
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targetsQ33780945
Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignanciesQ33788643
DNA instability at chromosomal fragile sites in cancerQ34152853
Rare copy number variants observed in hereditary breast cancer cases disrupt genes in estrogen signaling and TP53 tumor suppression networkQ34318239
NCG 5.0: updates of a manually curated repository of cancer genes and associated properties from cancer mutational screenings.Q34499917
copy number variation analysis in familial BRCA1/2-negative Finnish breast and ovarian cancerQ34964524
Incidence of multiple primary cancers and interval between first and second primary cancersQ35051898
New malignancies after squamous cell carcinoma and melanomas: a population-based study from NorwayQ35124575
The Candidate Cancer Gene Database: a database of cancer driver genes from forward genetic screens in miceQ35254569
A clinical and genetic analysis of multiple primary cancer referrals to genetics servicesQ35477924
Patterns of somatic uniparental disomy identify novel tumor suppressor genes in colorectal cancer.Q36139202
Epigenetic instability of imprinted genes in human cancersQ36370887
Germline DNA copy number variation in familial and early-onset breast cancerQ36393187
Delineation of a de novo 7q21.3q31.1 Deletion by CGH-SNP Arrays in a Girl with Multiple Congenital Anomalies Including Severe Glaucoma.Q37180729
Risk of second primary malignancies in women with breast cancer: Results from the European prospective investigation into cancer and nutrition (EPIC).Q50962764
LOH and copy neutral LOH (cnLOH) act as alternative mechanism in sporadic colorectal cancers with chromosomal and microsatellite instability.Q53290401
Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosisQ61596133
Increased frequency of 20q gain and copy-neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomasQ62978032
Genomic profile of a Li-Fraumeni-like syndrome patient with a 45,X/46,XX karyotype, presenting neither mutations in TP53 nor clinical stigmata of Turner syndromeQ63378058
Refined mapping of the region of loss of heterozygosity on the long arm of chromosome 7 in human breast cancer defines the location of a second tumor suppressor gene at 7q22 in the region of the CUTL1 geneQ77340270
Prenatal diagnosis and molecular cytogenetic characterization of a de novo interstitial deletion of 7q (7q22.1→q31.1)Q86516734
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P304page(s)41677
P577publication date2017-01-31
P1433published inScientific ReportsQ2261792
P1476titleGermline large genomic alterations on 7q in patients with multiple primary cancers
P478volume7

Search more.